Chromatin control of herpes simplex virus lytic and latent infection

Nature Reviews Microbiology

Volumn 6, Issue 3, 2008, Pages 211-221

  Knipe, David M ^a   Cliffe, Anna ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; VIRUS DNA;

CELL TYPE; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; DRUG DESIGN; EPITHELIUM CELL; EUCHROMATIN; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HETEROCHROMATIN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; SENSORY NERVE CELL; VIRUS CELL INTERACTION; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS TRANSMISSION;

ANIMALS; CELL NUCLEUS; CHROMATIN; DNA, VIRAL; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; HERPES SIMPLEX; HUMANS; NEURONS; SIMPLEXVIRUS; VIRUS ACTIVATION; VIRUS LATENCY;

SIMPLEXVIRUS;

EID: 39149132854     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1794     Document Type: Review

References (133)

1. Seeger. C., Zoulim, F. & Mason, W. S. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2977-3029 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
2. Pellett, P. E. & Roizman, B. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2479-2500 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
3. Roizman, B., Knipe, D. M. & Whitley, R. J. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2501-2602 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
4. Fisman, D. N., Lipsitch, M., Hook, E. W. & Goldie, S. J. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm. Dis. 29, 608-622 (2002).
5. Kimberlin, D. W. Neonatal herpes simplex infection. Clin. Microbiol. Rev. 17, 1-13 (2004).
6. Wald, A. & Link, K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J. Infect. Dis. 185, 45-52 (2002).
7. Freeman, E. E. et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: Systematic review and meta-analysis of longitudinal studies. AIDS 20, 73-83 (2006).
8. Jenuwein, T. & Allis, C. D. Translating the histone code. Science 293, 1074-1080 (2001).
9. Margolis, T. P. et al. Spontaneous reactivation of herpes simplex virus type 1 in latently infected murine sensory ganglia. J. Virol. 81, 11069-11074 (2007).
10. Corey, L., Wald, A. & Davis, L. G. Subclinical shedding of HSV: Its potential for reduction by antiviral therapy. Adv. Exp. Med. Biol. 394, 11-16 (1996).
11. Honess, R. W. & Rolzman, B. Regulation of herpesvirus macromolecular synthesis: Sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl Acad. Sci. U.S.A 72 1276-1280 (1975).
12. Wysocka, J. & Herr, W. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28, 294-304 (2003).
13. Carrozza, M. & DeLuca, N. Interactions of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 16, 3085-3093 (1996).
14. Smith, C. A., Bates, P., Rivera-Gonzalez, R., Gu, B. & DeLuca, N. A. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J. Virol. 67, 4676-4687 (1993).
15. Oh, J. & Fraser, N. W. Temporal association of the herpes simplex virus (HSV) genome with histone proteins during a lytic infection. J. Virol. 26 December 2007 (doi: 10.1128/JVI.00586-07).
16. Cohen, G. H. et al. Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J. Virol. 34, 521-531 (1980).
17. Pignatti, P. F. & Cassai, E. Analysis of herpes simplex virus nucleoprotein complexes extracted from infected cells. J. Virol. 36, 816-828 (1980).
18. Cereghini, S. & Yaniv, M. Assembly of transfected DNA into chromatin: structural changes in the origin-promoter-enhancer region upon replication. EMBO J. 3, 1243-1253 (1984).
19. Leinbach, S. S. & Summers, W. C. The structure of herpes simplex virus type 1 DNA as probed by micrococcal nuclease digestion. J. Gen. Virol. 51, 45-59 (1980).
20. Lentine, A. F. & Bachenheimer, S. L. Intracellular organization of herpes simplex virus type 1 DNA assayed by staphylococcal nuclease sensitivity. Virus Res. 16, 275-292 (1990).
21. Monier, K., Armas, J. C., Etteldorf, S., Ghazal, P. & Sullivan, K. F. Annexation of the interchromosomal space during viral infection. Nature Cell Biol. 2, 661-665 (2000).
22. L34 gene products promote the late maturation of viral replication compartments to the nuclear periphery. J. Virol. 78, 5591-5600 (2004).
23. Herrera, F. J. & Triezenberg, S. J. VP16-dependent association of chromatin-modifying coactivators and underrepresentation of histones at immediate-early gene promoters during herpes simplex virus infection. J. Virol. 78, 9689-9696 (2004).
24. Kent, J. R. et al. During lytic infection herpes simplex virus type 1 is associated with histones bearing modifications that correlate with active transcription. J. Virol. 78, 10178-10186 (2004).
25. Huang, J. et al. Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J. Virol. 80, 5740-5746 (2006).
26. Everett, R. D. Transactivation of transcription by herpes virus products: Requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 3, 3135-3141 (1984).
27. Gelman, I. H. & Silverstein, S. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl Acad. Sci. U.S.A. 82, 5265-5269 (1985).
28. O'Hare, P. & Hayward, G. S. Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J. Virol. 53, 751-760 (1985).
29. Quinlan, M. P. & Knipe, D. M. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell. Biol. 5, 957-963 (1985).
30. Nabel, G. J., Rice, S. A., Knipe, D. M. & Baltimore, D. Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells. Science 239, 1299-1302 (1988).
31. Sacks, W. R. & Schaffer, P. A. Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J. Virol. 61, 829-839 (1987).
32. Cai. W. & Schaffer. P. A. Herpes simplex virus type 1 ICPO regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66, 2904-2915 (1992).
33. Stow, N. D. & Stow, E. C. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67, 2571-2585 (1986).
34. Chen, J. & Silverstein, S. Herpes simplex viruses with mutations in the gene encoding ICPO are defective in gene expression. J. Virol. 66, 2916-2927 (1992).
35. Jordan, R. & Schaffer, P. A. Activation of gene expression by herpes simplex virus type 1 ICPO occurs at the level of mRNA synthesis. J. Virol. 71, 6850-6862 (1997).
36. Hobbs II, W. E. & DeLuca, N. A. Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICPO. J. Virol. 73, 8245-8255 (1999).
37. Poon, A. P. W., Silverstein, S. J. & Roizman, B. An early regulatory function required in a cell type-dependent manner is expressed by the genomic but not the cDNA copy of the herpes simplex virus 1 gene encoding infected cell protein 0. J. Virol. 76, 9744-9755 (2002).
38. Everett, R. D. ICPO, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22, 761-770 (2000).
39. Everett, R. D. et al. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICPO. J. Virol. 80, 7995-8005 (2006).
40. Everett, R. D. et al. The disruption of ND10 during herpes simplex virus infection correlates with the Vmw 110- and proteasome-dependent loss of several FML isoforms. J. Virol. 72, 6581-6591 (1998).
41. Chee, A. V., Lopez, P., Pandolfi, P. P. & Roizman, B. Promyelocytic leukemia protein mediates interferon-based anti-herpes simplex virus 1 effects. J. Virol. 77, 7101-7105 (2003).
42. Lomonte, P. et al. Functional interaction between class II histone deacetylases and ICPO of herpes simplex virus type 1. J. Virol. 78, 6744-6757 (2004).
43. Gu, H., Liang, Y., Mandel, G. & Roizman, B. Components of the REST/ CoREST/histone deacetylase repressor complex are disrupted, modified, and translocated in HSV-1-infected cells. Proc. Natl Acad. Sci. U.S.A. 102, 7571-7576 (2005).
44. Gu, H. & Roizman, B. Herpes simplex virus-infected cell protein O blocks the silencing of viral DNA by dissociating histone deacetylases from the CoREST-REST complex. Proc. Natl Acad. Sci. U.S.A. 104, 17134-17139 (2007).
45. Coleman, H. M. et al. Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICPO-mediated derepression. J. Gen. Virol. 89, 68-77 (2008).
46. He, G., Ylisastigui, I. & Margolis, D. M. The regulation of HIV-1 gene expression: The emerging role of chromatin. DNA Cell Biol. 21 697-705 (2002).
47. Poon, A. P., Gu, H. & Roizman, B. ICPO and the US3 protein kinase of herpes simplex virus 1 independently block histone deacetylation to enable gene expression. Proc. Natl Acad. Sci. U.S.A. 103, 9993-9998 (2006).
48. Taylor, T. J. & Knipe, D. M. Proteomics of herpes simplex virus replication compartments: Association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 78, 5856-5866 (2004).
49. Gao, M. & Knipe, D. M. Distal protein sequences can affect the function of a nuclear localization signal. Mol. Cell. Biol. 12, 1330-1339 (1992).
50. Kosz-Vnenchak, M., Coen, D. M. & Knipe, D. M. Restricted expression of herpes simplex virus lytic genes during establishment of latent infection by thymidine kinase-negative mutant viruses. J. Virol. 64, 5396-5402 (1990).
51. Valyi-Nagy, T., Deschmane, S. L., Dillner. A. & Fraser, N. W. Induction of cellular transcription factors in trigeminal ganglia of mice by corneal scarification, herpes simplex virus type 1 infection, and explantation of trigeminal ganglia. J. Virol. 65, 4142-4152 (1991).
52. Kramer, M. F., Chen, S. H., Knipe, D. M. & Coen, D. M. Accumulation of viral transcripts and DNA during establishment of latency by herpes simplex virus. J. Virol. 72, 1177-1185 (1998).
53. Garber, D. A., Schaffer, P. A. & Knipe, D. M. A LAT-associated function reduces productive-cycle gene expression during acute infection of murine sensory neurons with herpes simplex virus type 1. J. Virol. 71, 5885-5893 (1997).
54. Stevens. J. G., Wagner, E. K., Devi-Rao, G. B., Cook, M. L. & Feldman, L. T. RNA complementary to a herpesvirus alpha gene mRNA is prominent in latently infected neurons. Science 235, 1056-1059 (1987).
55. Sedarati, F., Margolls, T. P. & Sievens, J. G. Latent infection can be established with drastically restricted transcription and replication of the HSV-1 genome. Virology 192, 687-691 (1993).
56. Coen, D. M. et al. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc. Natl Acad. Sci. U.S.A. 86, 4736-4740 (1989).
57. Speck, P. G. & Simmons, A. Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1. J. Virol. 65, 4001-4005 (1991).
58. Margolis, T. P., Sedarati, F., Dobson, A. T., Feldman, L. T. & Stevens, J. G. Pathways of viral gene expression during acute neuronal infection with HSV-1. Virology 189, 150-160 (1992).
59. Stevens, J. G., Haarr, L., Porter, D. D., Cook, M. L. & Wagner, E. K. Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. J. Inf. Dis. 158 117-123 (1988).
60. Krause, P. R., Croen, K. D., Straus, S. E. & Ostrove, J. M. Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia. J. Virol. 62, 4819-4823 (1988).
61. Rock, D. L. et al. Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1. J. Virol. 61, 3820-3826 (1987).
62. Wagner, E. K. et al. Physical characterization of the herpes simplex virus latency-associated transcript in neurons. J. Virol. 62, 1194-1202 (1988).
63. Farrell, M. J., Dobson, A. T. & Feldmdn, L. T. Herpes simplex virus latency-associated transcript is a stable intron. Proc. Natl Acad. Sci. U.S.A. 88, 790-794 (1991).
64. Dobson, A. T. et al. Identification of the latency-associated transcript promotor by expression of rabbit β-globin mRNA in mouse sensory nerve ganglia latently infected with a recombinant herpes simplex virus. J. Virol. 65, 3844-3851 (1989).
65. Lokensgard, J. R., Berthomme, H. & Feldman, L. T. The latency-associated promoter of herpes simplex virus type 1 requires a region downstream of the transcription start site for long-term expression during latency. J. Virol. 71, 6714-6719 (1997).
66. Lokensgard, J. R., Bloom, D. C., Dobson, A. T. & Feldman, L. T. Long-term promoter activity during herpes simplex virus latency. J. Virol. 68, 7148-7156 (1994).
67. Batchelor, A. H. & O'Hare, P. Regulation and cell-type-specific activity of a promoter located upstream of the latency-associated transcript of herpes simplex virus type 1. J. Virol. 64, 3269-3279 (1990).
68. Zwaagstra, J. C. et al. Activity of herpes simplex virus type 1 latency-associated transcript (LAT) promoter in neuron-derived cells: evidence for neuron specificity and for a large LAT transcript. J. Virol. 64, 5019-5028 (1990).
69. Kenny, J. J. et al. Identification of a second ATF/CREB-like element in the herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) promoter. Virology 200, 220-235 (1994).
70. Spivack, J. G. & Fraser, N. W. Detection of herpes simplex virus type 1 transcripts during latent infection in mice. J. Virol. 61, 3841-3847 (1987); erratum in 62, 663 (1988).
71. Godowski, P. J. & Knipe, D. M. Transcriptional control of herpesvirus gene expression: Gene functions required for positive and negative regulation. Proc. Natl Acad. Sci. U.S.A. 83, 256-260 (1986).
72. Thomas, S. K., Gough, G., Latchman, D. S. & Coffin, R. S. Herpes simplex virus latency-associated transcript encodes a protein which greatly enhances virus growth, can compensate for deficiencies in immediate-early gene expression, and is likely to function during reactivation from virus latency. J. Virol. 73, 6618-6625 (1999).
73. Doerig, C., Pizer, L. I. & Wilcox, C. L. An antigen encoded by the latency-associated transcript in neuronal cell cultures latently infected with herpes simplex virus type 1. J. Virol. 65, 2724-2727 (1991).
74. Drolet, B. S. et al. The region of the herpes simplex virus type 1 LAT gene involved in spontaneous reactivation does not encode a functional protein. Virology 242, 221-232 (1998).
75. Javier, R. T., Stevens, J. G., Dissette, V. B. & Wagner, E. K. A herpes simplex virus transcript abundant in latently infected neurons is dispensable for establishment of the latent state. Virology 166 254-257 (1988).
76. Leib, D. A. et al. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63, 2893-2900 (1989).
77. Steiner, I. et al. Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection. EMBO J. 8, 505-511 (1989).
78. Sawtell, N. M. & Thompson, R. L. Rapid in vivo reactivation of herpes simplex virus in latently infected murine ganglionic neurons after transient hyperthermia. J. Virol. 66, 2150-2156 (1992).
79. Thompson, R. L. & Sawtell, N. M. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 71, 5432-5440 (1997).
80. Block, T. M. et al. An HSV LAT null mutant reactivates slowly from latent infection and makes small plaques on CV-1 monolayers. Virology 192, 618-630 (1993).
81. Bloom, D. C. et al. A 348-base-pair region in the latency-associated transcript facilitates herpes simplex virus type 1 reactivation. J. Virol. 70, 2449-2459 (1996).
82. Hill, J. M. et al. Quantitation of herpes simplex virus type 1 DNA and latency-associated transcripts in rabbit trigeminal ganglia demonstrates a stable reservoir of viral nucleic acids during latency. J. Virol. 70, 3137-3141 (1996).
83. Chen, S. H., Kramer, M. F., Schaffer, P. A. & Coen, D. M. A viral function represses accumulation of transcripts from productive-cycle genes in mouse ganglia latently infected with herpes simplex virus. J. Virol. 71, 5878-5884 (1997).
84. Mador, N., Goldenberg, D., Cohen, O., Panet, A. & Steiner, I. Herpes simplex virus type 1 latency-associated transcripts suppress viral replication and reduce immediate-early gene mRNA levels in a neuronal cell line. J. Virol. 72, 5067-5075 (1998).
85. Thompson, R. L. & Sawtell, N. M. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival. J. Virol. 75, 6660-6675 (2001).
86. Wang, Q.-Y. et al. Herpesviral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc. Natl Acad. Sci. U.S.A. 102, 16055-16059 (2005).
87. Perng, G. C. et al. Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science 287, 1500-1503 (2000).
88. Bloom, D. C. HSV LAT and neuronal survival. Int. Rev. Immunol. 23, 187-198 (2004).
89. Fraser, J. W., Deatly, A. M., Mellerick, M. I., Muggeridge, J. I. & Spivack, J. G. in Human Herpesvirus Infections: Pathogenesis, Diagnosis, and Treatment (eds Lopez, C. & Roizman, B.) 39-54 (Raven Press, New York, 1986).
90. Mellerick, D. M. & Fraser, N. W. Physical state of the latent herpes simplex virus genome in a mouse model system: Evidence suggesting an episomal state. Virology 158, 265-275 (1987).
91. Rock, D. L. & Fraser, N. W. Latent herpes simplex virus type 1 DNA contains two copies of the virion DNA joint region. J. Virol. 55, 849-852 (1985).
92. Rock, D. L. & Fraser, N. W. Detection of HSV-1 genome in central nervous system of latently infected mice. Nature 302. 523-525 (1983).
93. Deshmane, S. L. & Fraser, N. W. During latency, herpes simplex virus type 1 DNA is associated with nucleosomes in a chromatin structure. J. Virol. 63, 943-947 (1989).
94. Kubat, N. J., Amelio, A. L., Giordani, N. V. & Bloom, D. C. The herpes simplex virus type 1 latency-associated transcript (LAT) enhancer/rcr is hyperacelylated during latency independently of LAT transcription. J. Virol. 78, 12508-12518 (2004).
95. Dressler, G. R., Rock, D. L. & Fraser, N. W. Latent herpes simplex virus type 1 DNA is not extensively methylated in vivo. J. Gen. Virol. 68, 1761-1765 (1987).
96. Kubat, N. J., Tran, R. K., McAnany, P. & Bloom, D. C. Specific histone tail modification and not DNA methylation is a determinant of herpes simplex virus type 1 latent gene expression. J. Virol. 78, 1139-1149 (2004).
97. Amelio, A. L., McAnany, P. K. & Bloom, D. C. A chromatin insulator-like element in the herpes simplex virus type 1 latency-associated transcript region binds CCCTC-binding factor and displays enhancer-blocking and silencing activities. J. Virol. 80, 2358-2368 (2006).
98. Spivack, J. G. & Fraser, N. W. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection. J. Virol. 62, 1479-1485 (1988).
99. Amelio, A. L., Giordani, N. V., Kubat, N. J., O'Neil J. E. & Bloom, D. C. Deacetylation of the herpes simplex virus type 1 latency-associated transcript (LAT) enhancer and a decrease in LAT abundance precede an increase in ICPO transcriptional permissiveness at early times postexplant. J. Virol. 80, 2063-2068 (2006).
100. Kosz-Vnenchak, M., Jacobson, J., Coen, D. M. & Knipe, D. M. Evidence for a novel regulatory pathway for herpes simplex virus gene expression in trigeminal ganglion neurons. J. Virol. 67, 5383-5393 (1993).
101. Devi-Rao, G. B., Bloom. D. C., Stevens, J. G. & Wagner, E. K. Herpes simplex virus type 1 DNA replication and gene expression during explant-induced reactivation of latently infected murine sensory ganglia. J. Virol. 68, 1271-1282 (1994).
102. Arthur, J. L. et al. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. J. Virol. 75, 3885-3895 (2001).
103. Neumann, D. M., Bhattacharjee, P. S., Giordani, N. V., Bloom, D. C. & Hill, J. M. In vivo changes in the patterns of chromatin structure associated with the latent herpes simplex virus type 1 genome in mouse trigeminal ganglia can be detected at early times after butyrate treatment. J. Virol. 81, 13248-13253 (2007).
104. Kemp, L. M., Dent, C. L. & Latchman. D. S. Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamer-containing cellular promoters in neuronal cells, Neuron 4, 215-222 (1990).
105. Lillycrop, K. A. et al. The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons. Neuron 7, 381-390 (1991).
106. Hagmann, M., Georgiev, O., Schaffner, W. & Douville, P. Transcription factors interacting with herpes simplex virus alpha gene promoters in sensory neurons. Nucleic Acids Res. 23, 4978-4985 (1995).
107. Sears, A. E., Hukkanen, V, Labow, M. A., Levine, A. J. & Roizman, B. Expression of the herpes simplex virus 1 α transinducing factor (VP 16) does not induce reactivation of latent virus or prevent the establishment of latency in mice. J. Virol. 65, 2929-2935 (1991).
108. He, X. et al. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature 340, 35-41 (1989).
109. Kristie, T. M., Vogel, J. L. & Sears, A. E. Nuclear localization of the C1 factor (host cell factor) in sensory neurons correlates with reactivation of herpes simplex virus from latency. Proc. Natl Acad. Sci. U.S.A. 96, 1229-1233 (1999).
110. La Boissiere, S. Hughes, T & O'Hare, P. HCF-dependent nuclear import of VP16. EMBO J. 18, 480-489 (1999).
111. Grewal, S. I. & Jia, S. Heterochromatin revisited. Nature Rev. Genet. 8, 35-46 (2007).
112. Kim, D. H., Villeneuve, L. M., Morris, K. V. & Rossi, J. J. Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nature Struct. Mol. Biol. 13, 793-797 (2006).
113. Ng, K., Pullirsch, D, Leeb, M. & Wutz, A. Xist and the order of silencing. EMBO Rep. 8, 34-39 (2007).
114. Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129 1311-1323 (2007).
115. Kramer, M. F. & Coen, D. M. Quantification of transcripts from the ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simolex virus. J. Virol. 69, 1389-1399 (1995).
116. Chen, S.-H. et al. Neither LAT nor open reading frame P mutations increase expression of spliced or intron-containing ICPO transcripts in mouse ganglia latently infected with herpes simplex virus. J. Virol. 76, 4764-4772 (2002).
117. Pfeffer, S. et al. Identification of microRNAs of the herpesvirus family. Nature Methods 2, 269-276 (2005).
118. Cui. C. et al. Prediction and identification of herpes simplex virus 1-encoded microRNAs. J. Virol. 80, 5499-5508 (2006).
119. Gupta, A., Gartner, J. J., Sethupathy, P, Hatzigeorgiou, A. G. & Fraser, N. W. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442, 82-85 (2006).
120. Sugden, B. Virology: Micro mystery solution. Nature 442, 33-34 (2006).
121. Lieberman, P. M. Chromatin regulation of virus infection. Trends Microbiol. 14, 132-140 (2006).
122. Imperiale, M. J. & Major, E. O. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2263-2298 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
123. Berk. A. J. in Fields Virology 5th edn (eds Knipe, D. M. & Howley, P. M.) 2355-2394 (Lippincott, Williams & Wilkins, Philadelphia, 2007).
124. Saffert, R. T. & Kalejta, R. F Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80, 3863-3871 (2006).
125. Nevels, M., Paulus, C. & Shenk, T. Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone ceacetylation. Proc. Natl Acad. Sci. U.S.A. 101, 17234-17239 (2004).
126. Demonte, D., Quivy, V., Colette, Y. & Van Lint, C. Administration of HDAC inhibitors to reactivate HIV-1 expression in latent cellular reservoirs: Implications for the development of therapeutic strategies. Biochem. Pharmacol. 68, 1231-1238 (2004).
127. Ylisastigui, L., Archin, N. M., Lehrman, G., Bosch. R. J. & Margolis, D. M. Coaxing HIV-1 from resting CD4 T cells: Histone deacetylase inhibition allows latent viral expression. AIDS 18, 1101-1108 (2004).
128. Dudek, T. & Knipe, D. M. Replication-defective viruses as vaccines and vaccine vectors. Virology 344, 230-239 (2006).
129. Margolis, D. M. & Archin, N. M. Attacking HIV provirus; therapeutic strategies to disrupt persistent infection. Infect. Disord. Drug Targets 6, 369-376 (2006).
130. Lehrman, G. et al. Depletion of latent HIV-1 infection in vivo a proof-of-concept study. Lancet 366, 549-555 (2005).
131. Feng, W. H., Hong, G., Delecluse, J. J. & Kenney, S. C. Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas. J. Virol. 78, 1893-1902 (2004).
132. Feng, W. H. & Kenney, S. C. Valproic acid enhances the efficacy of chemotherapy in EBV-positive tumors by increasing lytic viral gene expression. Cancer Res. 66, 8762-8769 (2006).
133. Neumann, D. M., Bhattacharjee, P. S. & Hill, J. M. Sodium butyrate: A chemical inducer of in vivo reactivation of herpes simplex virus type 1 in the ocular mouse model. J. Virol. 81, 6106-6110 (2007).